Temozolomide in Elderly Patients With KPS < 70

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

September 30, 2010

Conditions
Primary Brain TumorGlioblastoma
Interventions
DRUG

Temozolomide

orally 150-200 mg/m2/day for 5 consecutive days every 4 week

Trial Locations (1)

75013

Pitie salpetriere hospital, Paris

All Listed Sponsors
collaborator

Association de Neuro-Oncologues d'Expression Francaise

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01242566 - Temozolomide in Elderly Patients With KPS < 70 | Biotech Hunter | Biotech Hunter